Skip to main content

Information updates

AIFA 2024 Research Grant Round Open - EOIs due 14 May 2024

The Allergy and Immunology Foundation of Australia (AIFA) 2024 grant round is now open and Expressions of Interest (EOIs) are invited from ASCIA members for AIFA research grants. EOIs are due by midnight on 14 May 2024 and the application form is on the AIFA website www.allergyimmunology.org.au/grants 

This year a total of $110,000 will be awarded, comprised of 8 grants that are listed below.

Allergy and Immunology Research
$40,000 AIFA Early Career and New Researcher Grants (4 x $10,000 available)
These grants encourage new research projects which do not yet have major funding. It is important that Early Career and New Researchers are supported to establish track records that will increase their chance of securing future research funding. These include early career scientist researchers, emerging clinician researchers (such as advanced allergy/immunology trainees), and other health professionals (such as dietitians, nurses, pharmacists).

Food Allergy Research Grants
$20,000 AIFA Prof Ann Kupa Food Allergy Grant
$15,000 AIFA DBV Technologies Food Allergy Grant

New AIFA Viatris Grant for Nurses
$20,000 AIFA Viatris Nurse Researcher of the Year
We are delighted to announce this new grant, which will be awarded to a late-stage nurse researcher to facilitate presentation of their completed, or soon to be completed, research at an appropriate international or national conference of their choosing.

Primary Immunodeficiency Research Grant
$15,000 AIFA CSL Behring HAE Clinical Research Grant

AIFA grants awarded in 2024 will be announced in September at the ASCIA 2024 Conference in Adelaide.

Thank you to new and long term supporters of AIFA research grants. Your generous support has contributed to the progress of clinical allergy and immunology research in Australia and New Zealand.

By 2026 AIFA aims to award a cumulative total of $1 million in research grants, selected by experts, for clinically important research into allergy and other immune diseases. Help us achieve this goal by donating at www.allergyimmunology.org.au/donate 

This news item was issued on 25 March 2024 by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.